title: [Prognostic factors and radiosensitivity of bladder cancer].
abstract: In the near future molecular biology will permit selection of patients with bladder cancer who can benefit more from radiotherapy and chemotherapy. There will also be an increase in the response rate due to the possibility of regulating the genes responsible for cellular radiosensitivity.
authors.affiliation: Area Funcional de Oncología, Hospital Virgen de la Arrixaca, El Palmar, Murcia, España. radioterapia@arrixaca.hura.es
authors.forename: M
authors.initials: M
authors.lastname: de las Heras González
authors.forename: J
authors.initials: J
authors.lastname: Salinas Ramos
authors.forename: I
authors.initials: I
authors.lastname: de la Fuente
authors.forename: A
authors.initials: A
authors.lastname: Navarrete Montoya
mesh_terms: D006801:Humans; D011379:Prognosis; D011836:Radiation Tolerance; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy*